These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6278726)

  • 21. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
    Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
    J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of the reproduction of a herpes simplex I virus carrying mutations in the thymidine kinase and DNA polymerase genes].
    Galegov GA; Nikolaeva SN; Gibadullin RA; Zhdanov VM
    Genetika; 1986 May; 22(5):892-4. PubMed ID: 3015723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inability to rescue viral genes from human cells biochemically transformed by herpes simplex virus type 2 DNA.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1981 Oct; 27(10):1123-8. PubMed ID: 6274496
    [No Abstract]   [Full Text] [Related]  

  • 26. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM; Furman PA; Gelep PT; Schaffer PA
    J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.
    Griffiths A
    Drug Resist Updat; 2011 Dec; 14(6):251-9. PubMed ID: 21940196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells.
    Balzarini J; De Clercq E
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):379-89. PubMed ID: 2545982
    [No Abstract]   [Full Text] [Related]  

  • 29. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of resistance mutants of viral polymerases.
    Oxford JS; al-Jabri AA; Stein CA; Levantis P
    Methods Enzymol; 1996; 275():555-600. PubMed ID: 9026659
    [No Abstract]   [Full Text] [Related]  

  • 31. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.
    Hall JD; Woodward S
    J Virol; 1989 Jun; 63(6):2874-6. PubMed ID: 2542598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral sensitivity following the introduction of acyclovir.
    Collins P
    Am J Med; 1988 Aug; 85(2A):129-34. PubMed ID: 2841855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical and genetic analysis of the herpes simplex virus DNA polymerase locus.
    Chartrand P; Crumpacker CS; Schaffer PA; Wilkie NM
    Virology; 1980 Jun; 103(2):311-26. PubMed ID: 6247818
    [No Abstract]   [Full Text] [Related]  

  • 35. Strategies of drug resistance in herpes simplex.
    Field HJ; Darby GK
    Nature; 1980 Aug; 286(5776):842. PubMed ID: 6251373
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.
    Panet A; Falk H
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1999-2006. PubMed ID: 6193244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus.
    Summers WP; Wagner M; Summers WC
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4081-4. PubMed ID: 172894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Location of non-temperature-sensitive genes on the genetic map of herpes simplex virus type 1.
    Brown SM; Jamieson AT
    IARC Sci Publ (1971); 1978; (24 Pt 1):33-9. PubMed ID: 221337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to mutagenesis of cells biochemically transformed by herpesvirus DNA fragments.
    Trkula D; Otsuka H; Plunkett W
    Biochem Biophys Res Commun; 1985 Dec; 133(3):1064-71. PubMed ID: 3002361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.